Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study of Barzolvolimab in Participants With Cold Induced Urticaria and Symptomatic Dermographism (EMBARQ-COLDU and SD)

The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to placebo in pa…

Chronic Inducible UrticariaCold UrticariaCold-Induced Urticaria+1 more

Celldex TherapeuticsNCT07266402